BioLab Holdings, Inc., a medical manufacturer headquartered in Phoenix and specializing in regenerative medicine and wound healing solutions, has launched a new multicenter hybrid platform trial to assess the clinical effectiveness of its amnion-based wound care products. The trial focuses on treating patients with chronic, hard-to-heal diabetic foot ulcers (DFUs) […]
admin
The Beauty and Wellness Industry Bringing Joy and Confidence
To me, beauty has always been about more than appearances—it’s about how it makes you feel. It’s a way to build confidence, practice self-care, and add a little joy to someone’s day. That belief is what led me to join CVS Health and continues to fuel my passion every day […]
Revolutionizing Melanoma Care: SkylineDx’s CP-GEP Test Minimizes Surgical Risks
SkylineDx, a leading diagnostics innovator specializing in molecular diagnostics for oncology, inflammatory, and infectious diseases, has announced significant findings from a Danish validation study recently published in the Journal of Surgical Oncology. This study confirms that SkylineDx’s Merlin Assay, also known as CP-GEP, can accurately identify cutaneous melanoma patients, particularly […]
Texas Cardiac Arrhythmia Institute First in U.S. to Implant Leadless Heart Failure Therapy Device
The Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center electrophysiologists have achieved a significant milestone by being the first medical team in the US to implant a novel, FDA-approved leadless device intended to provide cardiac resynchronization therapy to patients with heart failure. This therapy plays a vital role […]
Saluda Medical Rolls Out EVA Nationwide: A Breakthrough in Spinal Cord Stimulation Treatment
Saluda Medical, Inc., a leader in the advancement of neuromodulation technologies aimed at improving the lives of patients with chronic neurological disorders, has formally declared EVA’s full-scale commercial availability, its most recent advancements in sensing technology, all around the United States. This comes after EVA was approved by the US […]
FDA Grants Orphan Drug Designation to Amphix Bio’s Spinal Cord Injury Treatment
Amphix Bio, an innovative pre-clinical stage biotechnology company, has announced that its lead therapeutic candidate, AMFX-200, has received Orphan Drug Designation from the U.S. Food and Drug Administration for the treatment of acute spinal cord injury (SCI). This condition, which affects approximately 18,000 individuals annually in the United States, often […]
Microcurrent Therapy From Berlin Heals Shows Disease-Modifying Potential in Heart Failure Patients
Berlin Heals, an innovator in the field of bioelectric medicine aimed at treating heart failure, has announced the publication of a groundbreaking peer-reviewed study in the ESC Heart Failure journal. The study, titled “Two-year outcomes of a cardiac microcurrent device in chronic heart failure: A first-in-human pilot study,” highlights the […]
Novel Artificial Intelligence Models Detect Type 1 Diabetes Risk Before Clinical Onset
Developments from two studies highlighting the potential for machine learning leveraging artificial intelligence (AI) technology to improve early-stage identification of type 1 diabetes were presented as late-breaking poster sessions at the 85th Scientific Sessions of the American Diabetes Association® (ADA) in Chicago. Each year, around 64,000 Americans are diagnosed with type 1 diabetes. As many […]
FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance
FinThrive, Inc., a leading healthcare revenue management software-as-a-service (SaaS) provider, will have a significant presence at the 2025 Healthcare Financial Management Association (HFMA) Annual Conference, which will take place June 22-25 in Denver, Colorado. With high-profile speaking engagements, live demonstrations of cutting-edge solutions, and Agentic AI-driven innovation, FinThrive will showcase how its revenue cycle […]
NeuralCure AI Launches the First Diagnostic & Digital Twin OS for Preventative Care Clinics
NeuralCure AI today announced the official launch of its groundbreaking Diagnostic & Digital Twin Operating System, the first infrastructure platform purpose-built for the exploding preventative, regenerative, and patient-led healthcare market. As millions of Americans take control of their health, ordering their own labs and imaging, using AI to self-navigate symptoms, […]
